We frequently write about the challenges that mesothelioma patients face. This condition can be painful, debilitating and even fatal. Thankfully, certain treatments can improve the prognosis of certain patients diagnosed with mesothelioma. For example, some patients benefit from drug therapies, others from surgery, others from chemotherapy and others may benefit from a combination of these treatments.
Recently, international researchers determined that combining a certain compound with a specific immunosuppressant may help to make chemotherapy more successful for mesothelioma patients in particular. Their conclusions are based on lab tests and have yet to be confirmed in human patients. However, the research is promising and is therefore worth noting.